Journal of Experimental & Clinical Cancer Research

Papers
(The H4-Index of Journal of Experimental & Clinical Cancer Research is 65. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy290
Pyroptosis: a new paradigm of cell death for fighting against cancer277
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer266
Statins: a repurposed drug to fight cancer209
Emerging therapies for glioblastoma: current state and future directions200
Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer195
ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer191
Single‐cell RNA sequencing in cancer research180
TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer175
RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent164
Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies161
Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy159
Pyroptosis at the forefront of anticancer immunity156
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy124
Disulfidptosis: a new target for metabolic cancer therapy122
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets120
LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification119
Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway117
Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma113
Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion113
Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ111
Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer109
Immunotherapy for glioblastoma: the promise of combination strategies104
Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARα-CYP4X1 axis in colonic macrophages103
Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention102
LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond100
Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons99
The path to the clinic: a comprehensive review on direct KRASG12C inhibitors99
Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling99
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies98
microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis98
RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma97
Noncoding RNAs regulate alternative splicing in Cancer97
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer94
FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner94
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies93
Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma92
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response90
Alternative polyadenylation: methods, mechanism, function, and role in cancer90
CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis88
PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages88
Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma87
Dexosomes as a cell-free vaccine for cancer immunotherapy86
Interfering with Tumor Hypoxia for Radiotherapy Optimization82
Gastric cancer-derived exosomal miR-519a-3p promotes liver metastasis by inducing intrahepatic M2-like macrophage-mediated angiogenesis82
Gut microbiota influence tumor development and Alter interactions with the human immune system82
Hepatitis B virus P protein initiates glycolytic bypass in HBV-related hepatocellular carcinoma via a FOXO3/miRNA-30b-5p/MINPP1 axis81
HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer79
ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer79
SCD1, autophagy and cancer: implications for therapy78
The CD70-CD27 axis in oncology: the new kids on the block78
LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma78
The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors76
Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis76
METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy75
Circular RNA circ_001422 promotes the progression and metastasis of osteosarcoma via the miR-195-5p/FGF2/PI3K/Akt axis73
A specific tRNA half, 5’tiRNA-His-GTG, responds to hypoxia via the HIF1α/ANG axis and promotes colorectal cancer progression by regulating LATS273
Exosomal ANGPTL1 attenuates colorectal cancer liver metastasis by regulating Kupffer cell secretion pattern and impeding MMP9 induced vascular leakiness73
Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology73
Long noncoding RNA: a dazzling dancer in tumor immune microenvironment72
Recent advances in the developmental origin of neuroblastoma: an overview71
Induction of m6A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance69
Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis69
Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression67
CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway66
Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway65
0.038424968719482